Birchview Capital’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-781
| Closed | -$7.13K | – | 62 |
|
|
2024
Q1 | $7.13K | Hold |
781
| – | – | 0.01% | 59 |
|
|
2023
Q4 | $4.49K | Hold |
781
| – | – | ﹤0.01% | 58 |
|
|
2023
Q3 | $6.13K | Hold |
781
| – | – | 0.01% | 51 |
|
|
2023
Q2 | $41.6K | Hold |
781
| – | – | 0.03% | 53 |
|
|
2023
Q1 | $52K | Hold |
781
| – | – | 0.04% | 53 |
|
|
2022
Q4 | $31K | Hold |
781
| – | – | 0.02% | 55 |
|
|
2022
Q3 | $56K | Hold |
781
| – | – | 0.04% | 55 |
|
|
2022
Q2 | $42K | Hold |
781
| – | – | 0.03% | 59 |
|
|
2022
Q1 | $99K | Hold |
781
| – | – | 0.07% | 60 |
|
|
2021
Q4 | $92K | Sell |
781
-2
| -0.3% | -$264 | 0.06% | 65 |
|
|
2021
Q3 | $113K | Buy |
+783
| New | +$132K | 0.08% | 62 |
|
|
2021
Q2 | – | Sell |
-790
| Closed | -$238K | – | 63 |
|
|
2021
Q1 | $238K | Hold |
790
| – | – | 0.14% | 51 |
|
|
2020
Q4 | $110K | Hold |
790
| – | – | 0.06% | 48 |
|
|
2020
Q3 | $147K | Hold |
790
| – | – | 0.1% | 49 |
|
|
2020
Q2 | $118K | Hold |
790
| – | – | 0.07% | 50 |
|
|
2020
Q1 | $71K | Hold |
790
| – | – | 0.06% | 44 |
|
|
2019
Q4 | $130K | Buy |
790
+661
| +512% | +$210K | 0.09% | 49 |
|
|
2019
Q3 | $62K | Hold |
129
| – | – | 0.04% | 48 |
|
|
2019
Q2 | $120K | Hold |
129
| – | – | 0.07% | 48 |
|
|
2019
Q1 | $141K | Buy |
129
+2
| +2% | +$2.15K | 0.09% | 46 |
|
|
2018
Q4 | $97K | Sell |
127
-155
| -55% | -$189K | 0.09% | 48 |
|
|
2018
Q3 | $390K | Hold |
282
| – | – | 0.25% | 40 |
|
|
2018
Q2 | $382K | Hold |
282
| – | – | 0.26% | 35 |
|
|
2018
Q1 | $528K | Hold |
282
| – | – | 0.35% | 27 |
|
|
2017
Q4 | $479K | Buy |
282
+46
| +19% | +$124K | 0.28% | 24 |
|
|
2017
Q3 | $722K | Hold |
236
| – | – | 0.37% | 19 |
|
|
2017
Q2 | $1.05M | Hold |
236
| – | – | 0.56% | 13 |
|
|
2017
Q1 | $807K | Hold |
236
| – | – | 0.45% | 16 |
|
|
2016
Q4 | $301K | Hold |
236
| – | – | 0.19% | 27 |
|
|
2016
Q3 | $917K | Hold |
236
| – | – | 0.54% | 12 |
|
|
2016
Q2 | $1.69M | Hold |
236
| – | – | 1.23% | 7 |
|
|
2016
Q1 | $3.87M | Hold |
236
| – | – | 2.76% | 4 |
|
|
2015
Q4 | $3.14M | Hold |
236
| – | – | 1.81% | 4 |
|
|
2015
Q3 | $2.81M | Hold |
236
| – | – | 1.81% | 4 |
|
|
2015
Q2 | $7.64M | Buy |
236
+15
| +7% | +$617K | 4.04% | 3 |
|
|
2015
Q1 | $7.63M | Hold |
221
| – | – | 4.01% | 3 |
|
|
2014
Q4 | $5.07M | Buy |
+221
| New | +$7.58M | 2.94% | 4 |
|
Birchview Capital's YTEN Position: Q2 2024 in Review
Birchview Capital sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 781 shares — an estimated $7.13K sold.
Birchview Capital first reported a position in YTEN in Q4 2014 and held it in 37 quarters. The position peaked at $7.64M in Q2 2015. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.
- Birchview Capital reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Birchview Capital sold 781 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $7.13K.
- Birchview Capital first reported a position in Yield10 Bioscience, Inc. Common Stock in Q4 2014 and held it in 37 quarters.
- Birchview Capital's Yield10 Bioscience, Inc. Common Stock position peaked at $7.64M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.
Based on Birchview Capital's 13F filing for Q2 2024, filed 13 Aug 2024.